Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation
To access this article, please choose from the options below
PII: S0145-2126(05)00064-0
doi:10.1016/j.leukres.2005.01.017
© 2005 Elsevier Ltd. All rights reserved.
